LDOS NYSE Week ended 24 Jul 2026

Weekly Investor Report

Leidos Holdings Inc · Technology · Information Technology Services

Open interactive chart View report data
Latest close 112.1 USD
5.3% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -25.0% below the Trend Line and sits at 12.6% of its 52-week range. The latest completed week returned 5.3%, after a 10.2% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers. Options positioning is mixed with 35/100 conviction, while the latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal; earnings are due in 3d.

Setup score 25 out of 100
Latest Close 112.1 USD 24 Jul 2026
1W Return 5.3% latest completed week
4W Return 10.2% short-term follow-through
12W Return -24.6% quarterly tape
Trend Breadth 55.8% 29 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 5.3% Latest completed week; four-week move 10.2%. Indicator stack 31/31 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 41.88% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Mixed 35/100 conviction; expected move 10.3%. News sentiment 53/100 60 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -25.0% below the Trend Line and sits at 12.6% of its 52-week range. The latest completed week returned 5.3%, after a 10.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0112-week average 0.02

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 10.2% over four weeks, -24.6% over 12 weeks, and -30.6% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W5.3%
4W10.2%
12W-24.6%
26W-41.0%
52W-30.6%
Active trend streak0 weeks
Active weeks in one year29
Trend breadth55.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.17Latest activity-pressure read.
Pressure change27.4%Four-week change in activity pressure.
Leadership-37.21Latest relative-leadership reading.
RS change15.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength84/100Blend of value, momentum, and quality. Underlying universe rank 17; rank 1 is best.
Value89/100Relative valuation strength. Underlying universe rank 12; rank 1 is best.
Quality84/100Profitability and accounting quality. Underlying universe rank 17; rank 1 is best.
Momentum11/100Medium-term price momentum. Underlying universe rank 90; rank 1 is best.
Growth34/100Revenue and earnings growth. Underlying universe rank 67; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework91/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
9.9x
Price divided by trailing earnings.
Price / sales
0.8x
Market value relative to trailing revenue.
EV / EBITDA
8.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
10.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
17.5%
Gross profit retained from each unit of revenue.
Operating margin
12.2%
Operating profit retained from revenue.
Free-cash-flow margin
12.3%
Free cash flow generated from revenue.
Return on invested capital
14.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
2.3%
Latest one-year revenue growth.
EPS growth
6.6%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
36.5%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.5%
Cash dividends relative to market value.
Buyback yield
4.2%
Net share repurchases relative to market value.
Shareholder yield
5.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

LDOS shows mixed options pressure with a 35/100 conviction score, put-call volume ratio of 1.28, expected move of 10.3%, and Sharemaestro trend signal inactive.

Conviction35/100
Expected move10.3%
Put/call volume1.28
Pressure-6
Speculation35
Volatility77
Trend agreement67
Open options detail
Insider activity20 / 0

20 acquisitions and 0 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment53/100

Weighted news tone is neutral across 60 relevant articles.

15 positive · 39 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move10.3%Nearest-chain priced movement where available.
52-week drawdown-45.0%Distance below the 52-week high.
13-week volatility5.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+7.0%Week of 3 Jul.
Worst week-12.8%Week of 8 May.
Latest week+5.3%Week of 24 Jul.

Shape of recent returns

Strong gains2
Modest gains8
Flat weeks0
Modest losses8
Sharp losses8
Recent vol5.6%13-week weekly-return volatility.
Base vol4.3%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew3.1% / -3.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape22/100

Trend, activity pressure, participation, and risk combine to a 22/100 tape read.

 Indicator analysis9/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.01; No reversal markers Next-Week ExpectancyNegative 41.88%

Next-week expectancy is negative with a 41.88% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors68/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Cornerstone Growth rank 93; Buyback Yield rank 14; Small Cap Core rank 13 SVQF91/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 93.0 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options51/100

LDOS shows mixed options pressure with a 35/100 conviction score, put-call volume ratio of 1.28, expected move of 10.3%, and Sharemaestro trend signal inactive.

Mixed · Options-market disagreement · Expected move 10.3% Sentiment53/100

Weighted news tone is neutral across 60 relevant articles.

Cumberland Partners Ltd Sells 10,000 Shares of Leidos Holdings, Inc. $LDOS Insiders20 / 0

20 acquisitions and 0 disposals in the latest 180-day insider tape.

 Earnings3d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026112.1 USD5.3%149.6 USD143.1 USD-1.17-37.216.7MOff
17 Jul 2026106.5 USD-0.5%152.0 USD142.9 USD-1.36-41.227.2MOff
10 Jul 2026107.0 USD-1.7%154.6 USD142.8 USD-1.39-42.366.9MOff
3 Jul 2026108.8 USD7.0%157.3 USD142.7 USD-1.49-41.128.6MOff
26 Jun 2026101.8 USD-5.0%159.8 USD142.5 USD-1.61-44.2710.3MOff
19 Jun 2026107.1 USD-12.0%162.7 USD142.4 USD-1.65-43.2213.8MOff
12 Jun 2026121.7 USD-1.8%165.3 USD142.3 USD-1.74-35.415.2MOff
5 Jun 2026124.0 USD-2.6%167.6 USD142.0 USD-1.67-34.266.4MOff
29 May 2026127.3 USD1.4%170.0 USD141.7 USD-1.53-34.566.7MOff
22 May 2026125.5 USD1.9%172.0 USD141.4 USD-1.59-34.944.9MOff
15 May 2026123.2 USD-4.9%174.1 USD141.1 USD-1.60-36.038.0MOff
8 May 2026129.6 USD-12.8%176.1 USD140.8 USD-1.67-33.069.5MOff
1 May 2026148.7 USD2.2%178.0 USD140.5 USD-1.79-21.994.3MOff
24 Apr 2026145.5 USD-5.9%179.5 USD140.0 USD-1.76-23.244.0MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.